<DOC>
	<DOC>NCT01848470</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and tolerability of 3 multiple and escalating dose regimens of CG400549 administered orally in healthy volunteers.</brief_summary>
	<brief_title>Multiple Ascending Doses Study of CG400549</brief_title>
	<detailed_description>This is a Phase 1, 3 cohorts study consisting of a randomised, double-blind, and placebo-controlled design.</detailed_description>
	<criteria>Age:1855 years, inclusive Body Mass Index :1930 kg/m2, inclusive Sex:male Other criteria:healthy; nonsmoking or smoking â‰¤ 10 cigarettes/day Evidence of clinically relevant pathology History of bacterial or viral infection requiring treatment with antibiotics or antivirals within 1 month of study Presence or history of esophageal or gastroduodenal ulceration within 1 month before screening.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>